# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Clinical Criteria

Extent: E+W+S+N.I.

Any person with at least one of the following clinical forms:
Food-borne and wound botulism
At least one of the following two:
Bilateral cranial nerve impairment (for example, diplopia, blurred vision, dysphagia, bulbar weakness);
Peripheral symmetric paralysis.
Infant botulism
Any infant with at least one of the following six:
Constipation;
Lethargy;
Difficulty in sucking or feeding;
Ptosis;
Dysphagia;
General muscle weakness.
The type of botulism usually encountered in infants (< 12 months of age) can affect children also over 12 months of age and occasionally adults, with altered gastrointestinal anatomy and microflora

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.2/division/1 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.2/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.